Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Sep 18, 2023 2:30pm
135 Views
Post# 35641866

RE:Well, that was another fun little stop loss raid...

RE:Well, that was another fun little stop loss raid...What buyers are going to start jumping in Angler.? Instiutional Investors.?? LOL... yeah right... that'll happen.

What's the current % held by institutions, is it even 2%..? And it has been at this level for years.... Nothing Matt and Co says, and no matter how many times they open their war-room for inspection to 'big' pharma' there is still no investment.

So what buyers are going to jump in Angler...? The answer is retail traders, because no-one else will touch this pile of dog doo with a 6 ft pole.

If the Pan Can trial is going to be such a home run to get going, then really, we should be expecting big money to come flooding in... BUT, if it doesn't what will your excuse be this time.

For a company on the very cusp of success, the market sure doesn't seem excited.
<< Previous
Bullboard Posts
Next >>